<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The chemical versatility of its structure has led to the use of this compound as a starting biological material for the synthesis of new antifungal eugenol derivative agents to reduce nosocomial infections caused by 
 <italic class="italic">Candida</italic> spp., especially in patients admitted to an intensive care unit.
 <sup class="sup">
  <xref ref-type="bibr" rid="ref19" class="xref">19</xref>
 </sup> The antifungal activity of eugenol against clinically relevant fungi, including fluconazole-resistant strains, has also been observed for clove essential oil, which is able to inhibit 
 <italic class="italic">Aspergillus</italic> and 
 <italic class="italic">Candida</italic> species (such as 
 <italic class="italic">C. albicans</italic>, 
 <italic class="italic">C. tropicalis</italic>, and 
 <italic class="italic">Candida parapsilosis</italic>) and fluconazole-resistant 
 <italic class="italic">C. albicans</italic> isolates, as well as clinical dermatophyte strains.
 <sup class="sup">
  <xref ref-type="bibr" rid="ref20" class="xref">20</xref>
 </sup>
</p>
